Kesmalea Therapeutics ApS
APSIn liquidationAdvertising protectionCVR 41804505Amaliegade 37, 1256 København KForskning og eksperimentel udvikling indenfor bioteknologi· NACE 721100Est. 2020 · 5 years old— employees
Loading company…
Kesmalea Therapeutics ApS is a Danish APS based in København K, operating in the Forskning og eksperimentel udvikling indenfor bioteknologi sector. Incorporated in 2020, the company reported revenue of -3,1 mio. kr. in its latest annual filing.
In its most recent annual report (2021), Kesmalea Therapeutics ApS reported a gross profit of -3,1 mio. kr.. The bottom line showed a net loss of 3,3 mio. kr..
At the end of 2021, current assets covered short-term debt 28.5 times.